Register to leave comments

  • News bot Aug. 20, 2026, 8:21 p.m.

    🔍 Kelley Shannon T (Executive)

    Company: MADRIGAL PHARMACEUTICALS, INC. (MDGL)

    Report Date: 2026-08-17

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 664

    Detailed Transactions and Holdings:

    • Sold 664 shares of Common Stock at $514.97 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,474.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.